Villela CG[au] - Search Results

Year	Number of Results
2005	3
2006	3
2007	1
2008	3
2009	1
2024	0

1

Novel lipid mediator aspirin-triggered lipoxin A4 induces heme oxygenase-1 in endothelial cells.

Nascimento-Silva V, Arruda MA, Barja-Fidalgo C, Villela CG, Fierro IM. Nascimento-Silva V, et al. Among authors: villela cg. Am J Physiol Cell Physiol. 2005 Sep;289(3):C557-63. doi: 10.1152/ajpcell.00045.2005. Epub 2005 May 18. Am J Physiol Cell Physiol. 2005. PMID: 15901601 Free article.

2

Late, but not early, inhibition of soluble guanylate cyclase decreases mortality in a rat sepsis model.

Fernandes D, Sordi R, Pacheco LK, Nardi GM, Heckert BT, Villela CG, Lobo AR, Barja-Fidalgo C, Assreuy J. Fernandes D, et al. Among authors: villela cg. J Pharmacol Exp Ther. 2009 Mar;328(3):991-9. doi: 10.1124/jpet.108.142034. Epub 2008 Dec 10. J Pharmacol Exp Ther. 2009. PMID: 19073910

3

Nitric oxide-dependent reduction in soluble guanylate cyclase functionality accounts for early lipopolysaccharide-induced changes in vascular reactivity.

Fernandes D, da Silva-Santos JE, Duma D, Villela CG, Barja-Fidalgo C, Assreuy J. Fernandes D, et al. Among authors: villela cg. Mol Pharmacol. 2006 Mar;69(3):983-90. doi: 10.1124/mol.105.015479. Epub 2005 Dec 2. Mol Pharmacol. 2006. PMID: 16326931

4

ATL-1, an analogue of aspirin-triggered lipoxin A4, is a potent inhibitor of several steps in angiogenesis induced by vascular endothelial growth factor.

Cezar-de-Mello PF, Vieira AM, Nascimento-Silva V, Villela CG, Barja-Fidalgo C, Fierro IM. Cezar-de-Mello PF, et al. Among authors: villela cg. Br J Pharmacol. 2008 Mar;153(5):956-65. doi: 10.1038/sj.bjp.0707650. Epub 2008 Jan 14. Br J Pharmacol. 2008. PMID: 18193074 Free PMC article.

5

Immunolocalization of an osteopontin-like protein in dense granules of Toxoplasma gondii tachyzoites and its association with the parasitophorous vacuole.

Cortez E, Stumbo AC, Saldanha-Gama R, Villela CG, Barja-Fidalgo C, Rodrigues CA, das Graças Henriques M, Benchimol M, Barbosa HS, Porto LC, Carvalho L. Cortez E, et al. Among authors: villela cg. Micron. 2008;39(1):25-31. doi: 10.1016/j.micron.2007.08.007. Epub 2007 Sep 5. Micron. 2008. PMID: 17931871

6

Aspirin-triggered Lipoxin A4 inhibition of VEGF-induced endothelial cell migration involves actin polymerization and focal adhesion assembly.

Cezar-de-Mello PF, Nascimento-Silva V, Villela CG, Fierro IM. Cezar-de-Mello PF, et al. Among authors: villela cg. Oncogene. 2006 Jan 5;25(1):122-9. doi: 10.1038/sj.onc.1209002. Oncogene. 2006. PMID: 16132039

7

Involvement of phosphatidylinositol-3 kinase-Akt and nuclear factor kappa-B pathways in the effect of frutalin on human lymphocyte.

Brando-Lima AC, Saldanha-Gama RF, Pereira CR, Villela CG, Sampaio AL, Monteiro-Moreira AC, Henriques Md, Moreira RA, Barja-Fidalgo C. Brando-Lima AC, et al. Among authors: villela cg. Int Immunopharmacol. 2006 Mar;6(3):465-72. doi: 10.1016/j.intimp.2005.09.008. Epub 2005 Oct 12. Int Immunopharmacol. 2006. PMID: 16428082

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

7 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year